Toward prediction of class II mouse major histocompatibility complex peptide binding affinity: in silico bioinformatic evaluation using partial least squares, a robust multivariate statistical technique

被引:17
作者
Hattotuwagama, Channa K. [1 ]
Toseland, Christopher P. [1 ]
Guan, Pingping [1 ]
Taylor, Debra J. [1 ]
Hemsley, Shelley L. [1 ]
Doytchinova, Irini A. [1 ]
Flower, Darren R. [1 ]
机构
[1] Univ Oxford, Jenner Inst, Compton RG20 7NN, Berks, England
关键词
D O I
10.1021/ci050380d
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The accurate identification of T-cell epitopes remains a principal goal of bioinformatics within immunology. As the immunogenicity of peptide epitopes is dependent on their binding to major histocompatibility complex (MHC) molecules, the prediction of binding affinity is a prerequisite to the reliable prediction of epitopes. The iterative self-consistent ( ISC) partial-least-squares (PLS)-based additive method is a recently developed bioinformatic approach for predicting class II peptide-MHC binding affinity. The ISC-PLS method overcomes many of the conceptual difficulties inherent in the prediction of class II peptide-MHC affinity, such as the binding of a mixed population of peptide lengths due to the open-ended class II binding site. The method has applications in both the accurate prediction of class II epitopes and the manipulation of affinity for heteroclitic and competitor peptides. The method is applied here to six class II mouse alleles (I-A(b), I-A(d), I-A(k), I-A(s), I-E-d, and I-E-k and included peptides up to 25 amino acids in length. A series of regression equations highlighting the quantitative contributions of individual amino acids at each peptide position was established. The initial model for each allele exhibited only moderate predictivity. Once the set of selected peptide subsequences had converged, the final models exhibited a satisfactory predictive power. Convergence was reached between the 4th and 17th iterations, and the leave-one-out cross-validation statistical terms-q(2), SEP, and NC-ranged between 0.732 and 0.925, 0.418 and 0.816, and 1 and 6, respectively. The non-cross-validated statistical terms r(2) and SEE ranged between 0.98 and 0.995 and 0.089 and 0.180, respectively. The peptides used in this study are available from the AntiJen database (http://www.jenner.ac.uk/AntiJen). The PLS method is available commercially in the SYBYL molecular modeling software package. The resulting models, which can be used for accurate T-cell epitope prediction, will be made freely available online(http://www.jenner.ac.uk/MHCPred).
引用
收藏
页码:1491 / 1502
页数:12
相关论文
共 92 条
[1]   INTERACTION OF AN IMMUNODOMINANT EPITOPE WITH IA MOLECULES IN T-CELL ACTIVATION [J].
ADORINI, L ;
SETTE, A ;
BUUS, S ;
GREY, HM ;
DARSLEY, M ;
LEHMANN, PV ;
DORIA, G ;
NAGY, ZA ;
APPELLA, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (14) :5181-5185
[2]   DEVELOPMENT OF HIGH POTENCY UNIVERSAL DR-RESTRICTED HELPER EPITOPES BY MODIFICATION OF HIGH-AFFINITY DR-BLOCKING PEPTIDES [J].
ALEXANDER, J ;
SIDNEY, J ;
SOUTHWOOD, S ;
RUPPERT, J ;
OSEROFF, C ;
MAEWAL, A ;
SNOKE, K ;
SERRA, HM ;
KUBO, RT ;
SETTE, A ;
GREY, HM .
IMMUNITY, 1994, 1 (09) :751-761
[3]  
[Anonymous], SYBYL VERS 6 9
[4]   The majority of immunogenic epitopes generate CD4+ T cells that are dependent on MHC class II-bound peptide-flanking residues [J].
Arnold, PY ;
La Gruta, NL ;
Miller, T ;
Vignali, KM ;
Adams, PS ;
Woodland, DL ;
Vignali, DAA .
JOURNAL OF IMMUNOLOGY, 2002, 169 (02) :739-749
[5]   Peptide register shifting within the MHC groove: theory becomes reality [J].
Bankovich, AJ ;
Girvin, AT ;
Moesta, AK ;
Garcia, KC .
MOLECULAR IMMUNOLOGY, 2004, 40 (14-15) :1033-1039
[6]  
BERKOWER I, 1986, J IMMUNOL, V136, P2498
[7]  
BHAYANI H, 1988, J IMMUNOL, V141, P377
[8]   JenPep: a database of quantitative functional peptide data for immunology [J].
Blythe, MJ ;
Doytchinova, IA ;
Flower, DR .
BIOINFORMATICS, 2002, 18 (03) :434-439
[9]   The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003 [J].
Boeckmann, B ;
Bairoch, A ;
Apweiler, R ;
Blatter, MC ;
Estreicher, A ;
Gasteiger, E ;
Martin, MJ ;
Michoud, K ;
O'Donovan, C ;
Phan, I ;
Pilbout, S ;
Schneider, M .
NUCLEIC ACIDS RESEARCH, 2003, 31 (01) :365-370
[10]  
BOOTS AMH, 1991, IMMUNOLOGY, V74, P8